invention provides novel rotavirus vaccine compositions comprising rotavirus antigens , stabilizers and buffers . the buffers in the invention are pre - mixed in the rotavirus vaccine compositions to neutralize the high acidic ph of the stomach without requiring separate administration of an antacid before vaccine administration . vaccine compositions with buffers of the invention are stable liquid rotavirus vaccine formulations for oral administration .